Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies

Olga Nikolova, Russell Moser, Christopher Kemp, Mehmet Gönen, Adam A. Margolin

Abstract: In recent years, vast advances in biomedical technologies and comprehensive sequencing have revealed the genomic landscape of common forms of human cancer in unprecedented detail. The broad heterogeneity of the disease calls for rapid development of personalized therapies. Translating the readily available genomic data into useful knowledge that can be applied in the clinic remains a challenge. Computational methods are needed to aid these efforts by robustly analyzing genome-scale data from distinct experimental platforms for prioritization of targets and treatments.